Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-2-(methylsulphonyl)ethyl-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide

摘要

The present invention relates to crystalline forms of N-{6-(2-Hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide, to processes for their preparation, to pharmaceutical compositions comprising them and to their use in the control of disorders.